(Q39188053)

9 September 2017

title

A novel melittin-MhIL-2 fusion protein inhibits the growth of human ovarian cancer SKOV3 cells in vitro and in vivo tumor growth (English)

1 reference

9 September 2017

1 reference

Mingjun Liu

1

1 reference

9 September 2017

Jinbao Zong

2

1 reference

9 September 2017

Zimin Liu

3

1 reference

9 September 2017

Ling Li

4

1 reference

9 September 2017

Xu Zheng

5

1 reference

9 September 2017

Bin Wang

6

1 reference

9 September 2017

Guirong Sun

7

1 reference

9 September 2017

language of work or name

1 reference

27 February 2013

1 reference

Cancer Immunology, Immunotherapy

9 September 2017

published in

1 reference

9 September 2017

volume

62

1 reference

9 September 2017

issue

5

1 reference

9 September 2017

page(s)

889-895

1 reference

Specific thiazolidinediones inhibit ovarian cancer cell line proliferation and cause cell cycle arrest in a PPARγ independent manner

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

P73 regulates cisplatin-induced apoptosis in ovarian cancer cells via a calcium/calpain-dependent mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Weekly paclitaxel in ovarian cancer-the latest success story

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Selective in Vitro Growth of T Lymphocytes from Normal Human Bone Marrows

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

21 January 2018

Interleukin-2 toxicity

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Interleukin-2 in cancer treatment: disappointing or (still) promising? A review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Interleukin-2: inception, impact, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Isolation and characterization of modified species of a mutated (Cys125 -Ala) recombinant human interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Expression, purification, and characterization of a functional mutant recombinant human interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Anti-cancer effect of bee venom toxin and melittin in ovarian cancer cells through induction of death receptors and inhibition of JAK2/STAT3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Melittin activates endogenous phospholipase D during cytolysis of human monocytic leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Cytotoxic properties of eosinophil granule major basic protein for tumor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Induced expression of melittin, an antimicrobial peptide, inhibits infection by Chlamydia trachomatis and Mycoplasma hominis in a HeLa cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting IkappaBalpha kinase-NFkap

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Anti-cancer effect of bee venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-κB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Potent antitumor activity of a tumor-specific soluble TCR/IL-2 fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

The human ortholog of granulocyte macrophage colony-stimulating factor and interleukin-2 fusion protein induces potent ex vivo natural killer cell activation and maturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

Interleukin-2 augments natural killer cell activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1401-2

10.1007/S00262-013-1401-2

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference